Pol F. Boudes
2020 - Galectin Therapeutics
In 2020, Pol F. Boudes earned a total compensation of $1.1M as Chief Medical Officer at Galectin Therapeutics.
Compensation breakdown
| Bonus | $210,000 |
|---|---|
| Option Awards | $419,460 |
| Salary | $367,083 |
| Other | $85,938 |
| Total | $1,082,481 |
Boudes received $419.5K in option awards, accounting for 39% of the total pay in 2020.
Boudes also received $210K in bonus, $367.1K in salary and $85.9K in other compensation.
Rankings
In 2020, Pol F. Boudes' compensation ranked 8,304th out of 13,090 executives tracked by ExecPay. In other words, Boudes earned more than 36.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,304 out of 13,090 | 37th |
Division Manufacturing | 3,525 out of 5,621 | 37th |
Major group Chemicals And Allied Products | 1,425 out of 2,254 | 37th |
Industry group Drugs | 1,241 out of 1,954 | 37th |
Industry Pharmaceutical Preparations | 918 out of 1,459 | 37th |
Source: SEC filing on October 17, 2022.
Boudes' colleagues
We found two more compensation records of executives who worked with Pol F. Boudes at Galectin Therapeutics in 2020.